Senior Scientist, Process Development
Gilead
Listing collected from Gilead's career site. NextChapter is independent of Gilead.
Foster City, CA · Posted October 29, 2026
Just laid off? Start here: a plan for the first weeks
More in California job market · Senior Scientist jobs in California (37) · All Senior Scientist jobs (112) · Research jobs
Similar jobs
- Scientist, Medicinal Chemistry · General Proximity · San Francisco, CA
- Sr. Scientist/Principal Scientist, Medicinal Chemistry · General Proximity · San Francisco, CA
- Principal Scientist, Biotherapeutic Formulations · Halozyme Therapeutics · San Diego, CA
- Scientist I, Chemistry (Contract) · Pliant Therapeutics · CA
- Principal Scientist, Medicinal Chemistry · Iambic Therapeutics · San Diego, CA
- Senior Scientist II, Analytical Development · Revolution Medicines · Redwood City, CA
Where Foster City, CA ranks
Where Foster City, CA placed in our monthly rankings, month by month. Each month stays online at its own address.
November 2026
- #1Best cities for pay after cost of living$209k · of 100
- #1Best cities for pay after cost of living in the West Coast$209k · of 39
- #1Best cities for pay after cost of living in California$209k · of 32
- #1Best cities for director and executive jobs in the West Coast38% · of 71
- #1Best cities for data and analytics pay after cost of living$232k · of 28
- #1Best cities for technology pay after cost of living$209k · of 80
How AI is used in this kind of work
Among chemists, AI is already used for some of the tasks. Measured exposure for chemists: 26% (some).
Share of this job’s tasks that AI is already used for at work, from real usage. It is not a forecast of job loss, and a low number means no use seen yet. Source: Anthropic Economic Index.
Gilead has filed one layoff notice in the last twelve months, covering 84 workers, most recently April 2026. These are public filings with state labor departments, and an open role can sit alongside them. See the filings
About the job
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies